-transparent.png){kind=logo}
The ability of nomifensine to protect the dopaminergic cells of the substantia nigra and ventral tegmental areas against 6-hydroxydopamine-induced destruction was evaluated. Nomifensine at high doses (20 mg/kg, i.p.) protected the cells from the effects of low amounts of 6-hydroxydopamine (2 micrograms) injected intracerebrally. This protective effect was markedly decreased with an increased amount of 6-hydroxydopamine (8 micrograms), or by lower doses of nomifensine (6.7 mg/kg). These doses of nomifensine are higher than those required to protect dopaminergic nerve terminals.
Related Publications
G J Lees, and
R R Kydd, and
R J Horsburgh, and
J J Wright
August 1990,
Journal of neuroscience research,
G J Lees, and
R R Kydd, and
R J Horsburgh, and
J J Wright
August 1988,
Neuroscience,
G J Lees, and
R R Kydd, and
R J Horsburgh, and
J J Wright
September 1970,
The Journal of pharmacology and experimental therapeutics,
G J Lees, and
R R Kydd, and
R J Horsburgh, and
J J Wright
August 1987,
Life sciences,
G J Lees, and
R R Kydd, and
R J Horsburgh, and
J J Wright
August 1991,
Behavioral neuroscience,
G J Lees, and
R R Kydd, and
R J Horsburgh, and
J J Wright
February 1995,
Brain research,
G J Lees, and
R R Kydd, and
R J Horsburgh, and
J J Wright
June 1989,
Biochemical pharmacology,
G J Lees, and
R R Kydd, and
R J Horsburgh, and
J J Wright
January 1993,
Brain research bulletin,
G J Lees, and
R R Kydd, and
R J Horsburgh, and
J J Wright
April 2007,
Neurobiology of aging,
G J Lees, and
R R Kydd, and
R J Horsburgh, and
J J Wright
May 2012,
Journal of molecular neuroscience : MN,
